default search action

combined dblp search
author search
venue search
publication search

ask others

Amir Hosein Safari

> Home > Persons

Person information

Refine list

refinements active!

zoomed in on ?? of ?? records

view refined list in

export refined list as

showing all ?? records

2020 – today

see FAQ

What is the meaning of the colors in the publication lists?

2021
[j1]
- view
  - electronic edition via DOI (open access)
  - references & citations
  authority control:
- export record
  dblp key:
  - journals/almob/ZabetiDSSLC21
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/almob/ZabetiDSSLC21
Hooman Zabeti, Nick C. Dexter, Amir Hosein Safari, Nafiseh Sedaghat, Maxwell W. Libbrecht, Leonid Chindelevitch:
INGOT-DR: an interpretable classifier for predicting drug resistance in M. tuberculosis. Algorithms Mol. Biol. 16(1): 17 (2021)
[c2]
- view
  authority control:
- export record
  dblp key:
  - conf/bcb/SafariSZFCL21
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/bcb/SafariSZFCL21
Amir Hosein Safari, Nafiseh Sedaghat, Hooman Zabeti, Alpha Forna, Leonid Chindelevitch, Maxwell W. Libbrecht:
Predicting drug resistance in M. tuberculosis using a long-term recurrent convolutional network. BCB 2021: 29:1-29:10
2020
[c1]
- view
  - electronic edition via DOI (open access)
  - references & citations
  authority control:
- export record
  dblp key:
  - conf/wabi/ZabetiDSSLC20
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/wabi/ZabetiDSSLC20
Hooman Zabeti, Nick C. Dexter, Amir Hosein Safari, Nafiseh Sedaghat, Maxwell W. Libbrecht, Leonid Chindelevitch:
An Interpretable Classification Method for Predicting Drug Resistance in M. Tuberculosis. WABI 2020: 2:1-2:18

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.